These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7245091)

  • 1. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H; Jacob-Müller U
    Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro methods for the study of the effects of teratogens on preimplantation embryos.
    Spielmann H; Eibs HG; Jacob-Müller U
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):105-15. PubMed ID: 7446214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT; White KL
    Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on cyclophosphamide treatment during the preimplantation period. I. Differential sensitivity to maternal cyclophosphamide treatment.
    Spielmann H; Jacob-Müller U; Eibs HG; Beckord W
    Teratology; 1981 Feb; 23(1):1-5. PubMed ID: 7245082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
    Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
    Wilmer JL; Erexson GL; Kligerman AD
    Cancer Res; 1990 Aug; 50(15):4635-8. PubMed ID: 2369740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
    Struck RF; Alberts DS
    Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. II. Cyproterone acetate and medroxyprogesterone acetate treatment before implantation in vivo and in vitro.
    Eibs HG; Spielmann H; Jacob-Müller U; Klose J
    Teratology; 1982 Jun; 25(3):291-9. PubMed ID: 6214037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries.
    Desmeules P; Devine PJ
    Toxicol Sci; 2006 Apr; 90(2):500-9. PubMed ID: 16381661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
    Wilmer JL; Erexson GL; Kligerman AD
    Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
    Plowchalk DR; Mattison DR
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of acrolein in 4-hydroperoxycyclophosphamide-induced cell damage in vitro.
    Blomgren H; Hallström M
    Methods Find Exp Clin Pharmacol; 1991; 13(1):11-4. PubMed ID: 1908032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in teratology. A survey of methods for the study of drug actions during the preimplantation period.
    Spielmann H; Eibs HG
    Arzneimittelforschung; 1978; 28(10):1733-42. PubMed ID: 582678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.